English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  50691273    ???header.onlineuser??? :  360
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"gaggar a"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-24T09:31:08Z Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection Cheng X.; Uchida T.; Xia Y.; Umarova R.; CHUN-JEN LIU; Chen P.-J.; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.
臺大學術典藏 2022-01-24T09:31:05Z Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials Asahina Y.; CHUN-JEN LIU; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; Chen P.-J.; Enomoto N.
國立成功大學 2022 Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment Liu, C.J.;Sheen, I.S.;Chen, Chen C.Y.;Chuang, W.L.;Wang, H.Y.;Tseng, K.C.;Chang, T.T.;Yang, J.;Massetto, B.;Suri, V.;Camus, G.;Jiang, D.;Zhang, F.;Gaggar, A.;Hu, T.H.;Hsu, Y.C.;Lo, G.H.;Chu, Chu C.J.;Chen, J.J.;Peng, C.Y.;Chien, R.N.;Chen, P.J.
臺大學術典藏 2021-07-03T03:33:25Z Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection Cheng X.; Uchida T.; Xia Y.; Umarova R.; Liu C.-J.; PEI-JER CHEN; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.
臺大學術典藏 2021-07-03T03:33:22Z Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials Asahina Y.; Liu C.-J.; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN; Enomoto N.
國立成功大學 2021 Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV Pan, C.Q.;Chang, T.-T.;Bae, S.H.;Brunetto, M.;Seto, W.-K.;Coffin, Coffin C.S.;Tan, S.K.;Mo, S.;Flaherty, J.F.;Gaggar, A.;Nguyen, M.H.;Celen, M.K.;Thompson, A.;Gane, E.J.
臺大學術典藏 2020 Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial Criner G.J.; Gottlieb R.L.; Spinner C.D.; Le Turnier P.; Tsang O.T.Y.; Bernasconi E.; Roestenberg M.; Chai L.Y.A.; Castagna A.; Mullane K.M.; Ogbuagu O.; Malhotra P.; Soriano Viladomiu A.; Arribas L?pez J.R.; Cattelan A.M.; Ahn M.Y.; McPhail M.J.; Bhagani S.; Brainard D.M.; Gaggar A.; Wang H.; Blair C.; Cao H.; Hyland R.H.; Osinusi A.O.; Sengupta D.; SHAN-CHWEN CHANG; Sanyal A.J.; Huhn G.; Marty F.M.

Showing items 1-7 of 7  (1 Page(s) Totally)
1 
View [10|25|50] records per page